123 related articles for article (PubMed ID: 37992967)
1. Comparative Clinicopathologic and Genomic Analysis of Hepatocellular Neoplasm, Not Otherwise Specified, and Hepatoblastoma.
Zhou S; Sarabia SF; Estrine D; Ostrow D; Schmidt RJ; Warren M; Raca G; Shillingford N; Wang L; Pawel B; Stein JE; Biegel JA; Lopez-Terrada D; Mascarenhas L; Ji J
Mod Pathol; 2024 Feb; 37(2):100385. PubMed ID: 37992967
[TBL] [Abstract][Full Text] [Related]
2. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.
Sumazin P; Peters TL; Sarabia SF; Kim HR; Urbicain M; Hollingsworth EF; Alvarez KR; Perez CR; Pozza A; Najaf Panah MJ; Epps JL; Scorsone K; Zorman B; Katzenstein H; O'Neill AF; Meyers R; Tiao G; Geller J; Ranganathan S; Rangaswami AA; Woodfield SE; Goss JA; Vasudevan SA; Heczey A; Roy A; Fisher KE; Alaggio R; Patel KR; Finegold MJ; López-Terrada DH
J Hepatol; 2022 Oct; 77(4):1026-1037. PubMed ID: 35577029
[TBL] [Abstract][Full Text] [Related]
3. Molecular Profiling of a Hepatocellular Neoplasm Not Otherwise Specified (HCN-NOS) Demonstrates Distinct Molecular Features in Hepatoblastoma and HCC-Like Components.
Chen Wongworawat Y; Sarabia SF; Urbicain M; Francalanci P; Sumazin P; Alaggio R; López-Terrada DH
Pediatr Dev Pathol; 2024; 27(2):169-175. PubMed ID: 37903123
[TBL] [Abstract][Full Text] [Related]
4. The genomic landscape of hepatoblastoma and their progenies with HCC-like features.
Eichenmüller M; Trippel F; Kreuder M; Beck A; Schwarzmayr T; Häberle B; Cairo S; Leuschner I; von Schweinitz D; Strom TM; Kappler R
J Hepatol; 2014 Dec; 61(6):1312-20. PubMed ID: 25135868
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of a metastatic hepatocellular malignant neoplasm, not otherwise specified with chemotherapy and liver transplantation.
Seng MS; Berry B; Karpelowsky J; Thomas G; Mews C; Stormon M; Shun A; Cole C
Pediatr Blood Cancer; 2019 Apr; 66(4):e27603. PubMed ID: 30609257
[TBL] [Abstract][Full Text] [Related]
6. [Genomic imbalance and chromosome disorders in hepatoblastoma].
Gao H; Zhang ZB; Ou YL; Zhang KR; Wang WL
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):915-9. PubMed ID: 17533743
[TBL] [Abstract][Full Text] [Related]
7. Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.
Weber RG; Pietsch T; von Schweinitz D; Lichter P
Am J Pathol; 2000 Aug; 157(2):571-8. PubMed ID: 10934159
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of molecular genetic alterations in hepatoblastoma.
von Schweinitz D; Kraus JA; Albrecht S; Koch A; Fuchs J; Pietsch T
Med Pediatr Oncol; 2002 Feb; 38(2):104-8. PubMed ID: 11813174
[TBL] [Abstract][Full Text] [Related]
9. A 6-year-old boy with an atypical liver neoplasm harboring a novel RPS6KA3 variant.
Bustamante D; Abadie J
Lab Med; 2024 May; 55(3):391-393. PubMed ID: 37477894
[TBL] [Abstract][Full Text] [Related]
10. Comparative genomic hybridization analysis of hepatoblastoma reveals high frequency of X-chromosome gains and similarities between epithelial and stromal components.
Terracciano LM; Bernasconi B; Ruck P; Stallmach T; Briner J; Sauter G; Moch H; Vecchione R; Pollice L; Pettinato G; Gürtl B; Ratschek M; De Krijger R; Tornillo L; Bruder E
Hum Pathol; 2003 Sep; 34(9):864-71. PubMed ID: 14562281
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects.
Buendia MA
Med Pediatr Oncol; 2002 Nov; 39(5):530-5. PubMed ID: 12228912
[TBL] [Abstract][Full Text] [Related]
12. Hepatoblastoma and Pediatric Hepatocellular Carcinoma: An Update.
Ranganathan S; Lopez-Terrada D; Alaggio R
Pediatr Dev Pathol; 2020; 23(2):79-95. PubMed ID: 31554479
[TBL] [Abstract][Full Text] [Related]
13. Genomic Profiling Reveals Unique Molecular Alterations in Hepatoblastomas and Adjacent Hepatocellular Carcinomas in B6C3F1 Mice.
Bhusari S; Pandiri AR; Nagai H; Wang Y; Foley J; Hong HH; Ton TV; DeVito M; Shockley KR; Peddada SD; Gerrish KE; Malarkey DE; Hooth MJ; Sills RC; Hoenerhoff MJ
Toxicol Pathol; 2015 Dec; 43(8):1114-26. PubMed ID: 26289556
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular malignant neoplasm, NOS: a clinicopathological study of 11 cases from a single institution.
Zhou S; Venkatramani R; Gupta S; Wang K; Stein JE; Wang L; Mascarenhas L
Histopathology; 2017 Nov; 71(5):813-822. PubMed ID: 28660626
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
Carrillo-Reixach J; Torrens L; Simon-Coma M; Royo L; Domingo-Sàbat M; Abril-Fornaguera J; Akers N; Sala M; Ragull S; Arnal M; Villalmanzo N; Cairo S; Villanueva A; Kappler R; Garrido M; Guerra L; Sábado C; Guillén G; Mallo M; Piñeyro D; Vázquez-Vitali M; Kuchuk O; Mateos ME; Ramírez G; Santamaría ML; Mozo Y; Soriano A; Grotzer M; Branchereau S; de Andoin NG; López-Ibor B; López-Almaraz R; Salinas JA; Torres B; Hernández F; Uriz JJ; Fabre M; Blanco J; Paris C; Bajčiová V; Laureys G; Masnou H; Clos A; Belendez C; Guettier C; Sumoy L; Planas R; Jordà M; Nonell L; Czauderna P; Morland B; Sia D; Losic B; Buendia MA; Sarrias MR; Llovet JM; Armengol C
J Hepatol; 2020 Aug; 73(2):328-341. PubMed ID: 32240714
[TBL] [Abstract][Full Text] [Related]
16. MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma.
Woodfield SE; Shi Y; Patel RH; Chen Z; Shah AP; Srivastava RK; Whitlock RS; Ibarra AM; Larson SR; Sarabia SF; Badachhape A; Starosolski Z; Ghaghada KB; Sumazin P; Annis DA; López-Terrada D; Vasudevan SA
Sci Rep; 2021 Feb; 11(1):2967. PubMed ID: 33536467
[TBL] [Abstract][Full Text] [Related]
17. Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study.
Short SS; Kastenberg ZJ; Wei G; Bondoc A; Dasgupta R; Tiao GM; Watters E; Heaton TE; Lotakis D; La Quaglia MP; Murphy AJ; Davidoff AM; Mansfield SA; Langham MR; Lautz TB; Superina RA; Ott KC; Malek MM; Morgan KM; Kim ES; Zamora A; Lascano D; Roach J; Murphy JT; Rothstein DH; Vasudevan SA; Whitlock R; Lal DR; Hallis B; Bütter A; Baertschiger RM; Lapidus-Krol E; Putra J; Tracy ER; Aldrink JH; Apfeld J; Le HD; Park KY; Rich BS; Glick RD; Fialkowski EA; Utria AF; Meyers RL; Riehle KJ
Cancer; 2022 Jul; 128(14):2786-2795. PubMed ID: 35561331
[TBL] [Abstract][Full Text] [Related]
18. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
[TBL] [Abstract][Full Text] [Related]
19. Sarcomatoid hepatocellular carcinoma with hepatoblastoma-like features in an adult.
Cho MS; Lee SN; Sung SH; Han WS
Pathol Int; 2004 Jun; 54(6):446-50. PubMed ID: 15144405
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Liver Tumors: Updates in Classification.
Cho SJ
Surg Pathol Clin; 2020 Dec; 13(4):601-623. PubMed ID: 33183723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
